- Home
- IE vs RARE Comparison
IE vs RARE Comparison
Compare IE & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IE | RARE |
|---|---|---|
| Founded | 2020 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2022 | 2013 |
Fundamental Metrics
Financial Performance| Metric | IE | RARE |
|---|---|---|
| Price | $12.93 | $21.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 19 |
| Target Price | $18.50 | ★ $66.32 |
| AVG Volume (30 Days) | 1.7M | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.31 |
| EPS | ★ 0.79 | N/A |
| Revenue | $3,244,000.00 | ★ $673,000,000.00 |
| Revenue This Year | $32.09 | $13.40 |
| Revenue Next Year | $11.37 | $42.83 |
| P/E Ratio | $17.75 | ★ N/A |
| Revenue Growth | 11.82 | ★ 20.13 |
| 52 Week Low | $4.50 | $18.41 |
| 52 Week High | $21.55 | $40.21 |
Technical Indicators
Market Signals| Indicator | IE | RARE |
|---|---|---|
| Relative Strength Index (RSI) | 34.18 | 42.73 |
| Support Level | $11.56 | $19.61 |
| Resistance Level | $13.44 | $25.46 |
| Average True Range (ATR) | 0.99 | 0.80 |
| MACD | -0.25 | 0.10 |
| Stochastic Oscillator | 9.83 | 36.73 |
Price Performance
Historical ComparisonAbout IE Ivanhoe Electric Inc.
Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.